|
|
Article: Promising New Eyedrops for Allergic Conjunctivitis.(Brief Article)(Statistical Data Included)
- Article from:
- Family Practice News
- Article date:
- January 1, 2000
- Author:
CopyrightCOPYRIGHT 2000 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CHICAGO -- Olopatadine, a novel eyedrop that has antihistaminic and mast cell stabilizing actions, is a major advance in the treatment of allergic conjunctivitis, Dr. David Granet said at a seminar on allergic eye disease during the annual meeting of the American College of Allergy, Asthma, and Immunology.
"It works, it is safe down to age 3, you only need to use it two or three times per day, it rarely stings, and it is inexpensive. In my experience, it is pure compliance," said Dr. Granet, a pediatric ophthalmologist at the University of California, San Diego. "I use it myself."
Topical ocular antihistamine-decongestants such as levocabastine and ...